Cargando…
Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
Breast cancer (BC) is the most commonly diagnosed cancer among women and the leading cause of cancer death. Despite the advent of numerous diagnosis and treatment methods in recent years, this heterogeneous disease still presents great challenges in early diagnosis, curative treatments and prognosis...
Autores principales: | Chen, Zhanghan, Li, Zehuan, Li, Haoran, Jiang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709037/ https://www.ncbi.nlm.nih.gov/pubmed/31686838 http://dx.doi.org/10.2147/OTT.S215628 |
Ejemplares similares
-
Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan‐cancer
por: Chen, Zhanghan, et al.
Publicado: (2020) -
Immunotherapeutic interventions of Triple Negative Breast Cancer
por: Li, Zehuan, et al.
Publicado: (2018) -
Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases
por: Li, Danqi, et al.
Publicado: (2021) -
Promising diagnostic and therapeutic circRNAs for skeletal and chondral disorders
por: Chen, Gaoyang, et al.
Publicado: (2021) -
Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021)